Arndt Hartmann

14PUBLICATIONS
318CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 16, 2026
Immunohistochemical stratification of bladder small cell carcinoma reveals two major phenotypes with distinct therapeutic biomarker profiles.

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Aug 13, 2026
Anaphylactic Shock Probably due to a Cross-Reaction Between Cefuroxime and Piperacillin-Presentation of a Fatal Case, Diagnostic Considerations, and Literature Review.

|Jul 08, 2026
Cytokine-mediated activation of kidney-infiltrating CD8+ T cells enables their contribution to inflammation in human lupus nephritis.

|Nov 03, 2025
Renal hemangioblastoma and renal cell carcinoma with fibromyomatous stroma and hemangioblastoma-like areas belong to the spectrum of one entity.

Kiril Trpkov, Norel Salut, Inmaculada Ribera-Cortada

|Sep 11, 2025
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono Trial.

Hans-Christian Kolberg, Johannes Schumacher, Ramona Erber

Pageof 3

Frequent Collaborators

4 joint publications

Markus Eckstein

4 joint publications

Ramona Erber

3 joint publications

Peter A Fasching

2 joint publications

Holly R Harris